O	0	4	PI3K	PI3K	NN	B-NP
O	4	5	/	/	SYM	I-NP
O	5	8	Akt	Akt	NN	I-NP
O	8	9	-	-	HYPH	B-NP
O	9	18	dependent	dependent	JJ	I-NP
O	19	34	transcriptional	transcriptional	JJ	I-NP
O	35	45	regulation	regulation	NN	I-NP
O	46	49	and	and	CC	I-NP
O	50	60	activation	activation	NN	I-NP
O	61	63	of	of	IN	B-PP
O	64	67	BMP	BMP	NN	B-NP
O	67	68	-	-	HYPH	B-NP
O	68	69	2	2	CD	I-NP
O	69	70	-	-	HYPH	I-NP
O	70	74	Smad	Smad	NN	I-NP
O	75	84	signaling	signaling	NN	I-NP
O	85	87	by	by	IN	B-PP
O	88	90	NF	NF	NN	B-NP
O	90	91	-	-	HYPH	B-NP
O	91	97	kappaB	kappaB	NN	I-NP
O	98	100	in	in	IN	B-PP
B-Cell	101	111	metastatic	metastatic	JJ	B-NP
I-Cell	112	120	prostate	prostate	NN	I-NP
I-Cell	121	127	cancer	cancer	NN	I-NP
I-Cell	128	133	cells	cell	NNS	I-NP
O	133	134	.	.	.	O

O	136	146	BACKGROUND	BACKGROUND	NN	B-NP
O	146	147	:	:	:	O
B-Organ	148	152	Bone	Bone	NN	B-NP
O	153	166	morphogenetic	morphogenetic	JJ	I-NP
O	167	175	proteins	protein	NNS	I-NP
O	176	177	(	(	(	O
O	177	181	BMPs	BMP	NNS	B-NP
O	181	182	)	)	)	O
O	183	188	exert	exert	VBP	B-VP
O	189	203	osteoinductive	osteoinductive	JJ	B-NP
O	204	211	effects	effect	NNS	I-NP
O	212	214	in	in	IN	B-PP
B-Cancer	215	223	prostate	prostate	NN	B-NP
I-Cancer	224	230	cancer	cancer	NN	I-NP
O	231	232	(	(	(	O
B-Cancer	232	234	PC	PC	NN	B-NP
O	234	235	)	)	)	O
O	236	239	via	via	IN	B-PP
O	240	255	uncharacterized	uncharacterized	JJ	B-NP
O	256	266	mechanisms	mechanism	NNS	I-NP
O	266	267	.	.	.	O

O	268	270	In	In	IN	B-PP
O	271	275	this	this	DT	B-NP
O	276	281	study	study	NN	I-NP
O	281	282	,	,	,	O
O	283	285	we	we	PRP	B-NP
O	286	298	investigated	investigate	VBD	B-VP
O	299	306	whether	whether	IN	B-SBAR
O	307	310	the	the	DT	B-NP
B-Cellular_component	311	318	nuclear	nuclear	JJ	I-NP
O	319	332	transcription	transcription	NN	I-NP
O	333	339	factor	factor	NN	I-NP
O	340	342	NF	NF	NN	I-NP
O	342	343	-	-	HYPH	B-NP
O	343	349	kappaB	kappaB	NN	I-NP
O	349	350	,	,	,	O
O	351	361	implicated	implicate	VBN	B-VP
O	362	364	in	in	IN	B-PP
B-Cancer	365	367	PC	PC	NN	B-NP
O	368	378	metastasis	metastasis	NN	I-NP
O	378	379	,	,	,	O
O	380	382	is	be	VBZ	B-VP
O	383	391	involved	involve	VBN	I-VP
O	392	394	in	in	IN	B-PP
O	395	410	transcriptional	transcriptional	JJ	B-NP
O	411	421	regulation	regulation	NN	I-NP
O	422	425	and	and	CC	I-NP
O	426	436	activation	activation	NN	I-NP
O	437	439	of	of	IN	B-PP
O	440	443	BMP	BMP	NN	B-NP
O	443	444	-	-	HYPH	B-NP
O	444	445	2	2	CD	I-NP
O	446	448	or	or	CC	I-NP
O	449	452	BMP	BMP	NN	I-NP
O	452	453	-	-	HYPH	I-NP
O	453	454	4	4	CD	I-NP
O	454	455	/	/	SYM	I-NP
O	455	459	Smad	Smad	NN	I-NP
O	460	469	signaling	signaling	NN	I-NP
O	470	472	in	in	IN	B-PP
B-Cell	473	475	PC	PC	NN	B-NP
I-Cell	476	481	cells	cell	NNS	I-NP
O	481	482	.	.	.	O

O	483	490	METHODS	METHODS	NNS	B-NP
O	490	491	:	:	:	O
O	492	494	NF	NF	NN	B-NP
O	494	495	-	-	HYPH	B-NP
O	495	501	kappaB	kappaB	NN	I-NP
O	502	512	inhibition	inhibition	NN	I-NP
O	513	516	was	be	VBD	B-VP
O	517	525	achieved	achieve	VBN	I-VP
O	526	528	by	by	IN	B-PP
O	529	541	IkappaBalpha	IkappaBalpha	NN	B-NP
O	542	547	super	super	NN	I-NP
O	547	548	-	-	HYPH	B-NP
O	548	557	repressor	repressor	NN	I-NP
O	558	568	adenoviral	adenoviral	JJ	I-NP
O	569	575	vector	vector	NN	I-NP
O	576	579	and	and	CC	I-NP
O	580	590	activation	activation	NN	I-NP
O	591	594	was	be	VBD	B-VP
O	595	604	monitored	monitor	VBN	I-VP
O	605	607	by	by	IN	B-PP
O	608	612	EMSA	EMSA	NN	B-NP
O	613	616	and	and	CC	I-NP
O	617	625	reporter	reporter	NN	I-NP
O	626	632	assays	assay	NNS	I-NP
O	632	633	.	.	.	O

O	634	637	BMP	BMP	NN	B-NP
O	638	648	expression	expression	NN	I-NP
O	649	652	and	and	CC	O
O	653	663	activation	activation	NN	B-NP
O	664	667	was	be	VBD	B-VP
O	668	676	measured	measure	VBN	I-VP
O	677	679	by	by	IN	B-PP
O	680	683	PCR	PCR	NN	B-NP
O	684	687	and	and	CC	I-NP
O	688	696	reporter	reporter	NN	I-NP
O	697	703	assays	assay	NNS	I-NP
O	703	704	.	.	.	O

O	705	713	Promoter	Promoter	NN	B-NP
O	714	721	binding	binding	NN	I-NP
O	722	727	assay	assay	NN	I-NP
O	728	731	was	be	VBD	B-VP
O	732	741	performed	perform	VBN	I-VP
O	742	744	by	by	IN	B-PP
B-Cellular_component	745	754	chromatin	chromatin	NN	B-NP
O	755	774	immunoprecipitation	immunoprecipitation	NN	I-NP
O	775	776	(	(	(	O
O	776	780	ChIP	ChIP	NN	B-NP
O	780	781	)	)	)	O
O	782	787	assay	assay	NN	B-NP
O	787	788	.	.	.	O

O	789	794	Smad1	Smad1	NN	B-NP
O	794	795	/	/	SYM	O
O	795	796	5	5	CD	B-NP
O	796	797	/	/	SYM	I-NP
O	797	798	8	8	CD	I-NP
O	799	814	phosphorylation	phosphorylation	NN	I-NP
O	815	818	was	be	VBD	B-VP
O	819	827	measured	measure	VBN	I-VP
O	828	830	by	by	IN	B-PP
O	831	838	Western	Western	JJ	B-NP
O	839	843	blot	blot	NN	I-NP
O	844	852	analysis	analysis	NN	I-NP
O	852	853	.	.	.	O

O	854	861	RESULTS	RESULTS	NNS	B-NP
O	861	862	:	:	:	O
O	863	866	PCR	PCR	NN	B-NP
O	867	870	and	and	CC	O
O	871	879	chimeric	chimeric	JJ	B-NP
O	880	883	BMP	BMP	NN	I-NP
O	883	884	-	-	HYPH	B-NP
O	884	885	2	2	CD	I-NP
O	886	889	and	and	CC	I-NP
O	890	893	BMP	BMP	NN	I-NP
O	893	894	-	-	HYPH	I-NP
O	894	895	4	4	CD	I-NP
O	896	906	luciferase	luciferase	NN	I-NP
O	907	913	assays	assay	NNS	I-NP
O	914	925	demonstrate	demonstrate	VBP	B-VP
O	926	930	that	that	IN	B-SBAR
O	931	933	NF	NF	NN	B-NP
O	933	934	-	-	HYPH	B-NP
O	934	940	kappaB	kappaB	NN	I-NP
O	941	948	confers	confer	VBZ	B-VP
O	949	955	robust	robust	JJ	B-NP
O	956	959	and	and	CC	I-NP
O	960	969	selective	selective	JJ	I-NP
O	970	980	activation	activation	NN	I-NP
O	981	983	of	of	IN	B-PP
O	984	987	BMP	BMP	NN	B-NP
O	987	988	-	-	HYPH	O
O	988	989	2	2	CD	B-NP
O	990	992	in	in	IN	B-PP
O	993	996	p65	p65	NN	B-NP
O	997	1011	overexpressing	overexpressing	NN	I-NP
O	1012	1014	or	or	CC	I-NP
O	1015	1020	rhTNF	rhTNF	NN	I-NP
O	1020	1021	-	-	HYPH	B-NP
O	1021	1026	alpha	alpha	SYM	I-NP
O	1026	1027	-	-	HYPH	I-NP
O	1027	1037	stimulated	stimulate	VBN	I-NP
B-Cell	1038	1040	PC	PC	NN	I-NP
I-Cell	1041	1046	cells	cell	NNS	I-NP
O	1046	1047	.	.	.	O

O	1048	1058	Inhibition	Inhibition	NN	B-NP
O	1059	1061	of	of	IN	B-PP
O	1062	1064	NF	NF	NN	B-NP
O	1064	1065	-	-	HYPH	B-NP
O	1065	1071	kappaB	kappaB	NN	I-NP
O	1072	1085	significantly	significantly	RB	B-ADVP
O	1086	1093	reduced	reduce	VBD	B-VP
O	1094	1104	transcript	transcript	NN	B-NP
O	1105	1111	levels	level	NNS	I-NP
O	1112	1115	and	and	CC	O
O	1116	1125	autocrine	autocrine	JJ	B-NP
O	1126	1136	production	production	NN	I-NP
O	1137	1139	of	of	IN	B-PP
O	1140	1143	BMP	BMP	NN	B-NP
O	1143	1144	-	-	HYPH	O
O	1144	1145	2	2	CD	B-NP
O	1146	1148	by	by	IN	B-PP
O	1149	1154	rhTNF	rhTNF	NN	B-NP
O	1154	1155	-	-	HYPH	B-NP
O	1155	1160	alpha	alpha	SYM	I-NP
O	1161	1171	stimulated	stimulate	VBN	I-NP
B-Cell	1172	1174	C4	C4	NN	I-NP
I-Cell	1174	1175	-	-	HYPH	I-NP
I-Cell	1175	1177	2B	2B	NN	I-NP
I-Cell	1178	1183	cells	cell	NNS	I-NP
O	1184	1187	and	and	CC	B-PP
O	1188	1190	to	to	TO	B-PP
O	1191	1192	a	a	DT	B-NP
O	1193	1199	lesser	less	JJR	I-NP
O	1200	1206	extent	extent	NN	I-NP
O	1207	1209	by	by	IN	B-PP
O	1210	1213	the	the	DT	B-NP
O	1214	1222	parental	parental	JJ	I-NP
B-Cell	1223	1228	LNCaP	LNCaP	NN	I-NP
I-Cell	1229	1234	cells	cell	NNS	I-NP
O	1234	1235	.	.	.	O

O	1236	1245	Selective	Selective	JJ	B-NP
O	1246	1256	inhibition	inhibition	NN	I-NP
O	1257	1259	of	of	IN	B-PP
O	1260	1264	PI3K	PI3K	NN	B-NP
O	1264	1265	/	/	SYM	B-NP
O	1265	1268	Akt	Akt	NN	I-NP
O	1269	1279	suppressed	suppress	VBD	B-VP
O	1280	1283	the	the	DT	B-NP
O	1284	1286	NF	NF	NN	I-NP
O	1286	1287	-	-	HYPH	B-NP
O	1287	1293	kappaB	kappaB	NN	I-NP
O	1293	1294	-	-	HYPH	O
O	1294	1301	induced	induce	VBN	B-NP
O	1302	1305	BMP	BMP	NN	I-NP
O	1305	1306	-	-	HYPH	I-NP
O	1306	1307	2	2	CD	I-NP
O	1308	1316	promoter	promoter	NN	I-NP
O	1317	1325	activity	activity	NN	I-NP
O	1325	1326	.	.	.	O

O	1327	1338	Furthermore	Furthermore	RB	B-ADVP
O	1338	1339	,	,	,	O
O	1340	1351	suppression	suppression	NN	B-NP
O	1352	1354	of	of	IN	B-PP
O	1355	1357	NF	NF	NN	B-NP
O	1357	1358	-	-	HYPH	B-NP
O	1358	1364	kappaB	kappaB	NN	I-NP
O	1365	1375	activation	activation	NN	I-NP
O	1376	1385	decreased	decrease	VBD	B-VP
O	1386	1389	the	the	DT	B-NP
O	1390	1400	transcript	transcript	NN	I-NP
O	1401	1407	levels	level	NNS	I-NP
O	1408	1411	and	and	CC	O
O	1412	1415	BMP	BMP	NN	B-NP
O	1415	1416	-	-	HYPH	B-NP
O	1416	1417	2	2	CD	I-NP
O	1417	1418	-	-	HYPH	I-NP
O	1418	1425	induced	induce	VBN	I-NP
O	1426	1441	phosphorylation	phosphorylation	NN	I-NP
O	1442	1444	of	of	IN	B-PP
O	1445	1450	Smad1	Smad1	NN	B-NP
O	1450	1451	/	/	SYM	O
O	1451	1452	5	5	CD	B-NP
O	1452	1453	/	/	SYM	I-NP
O	1453	1454	8	8	CD	I-NP
O	1454	1455	,	,	,	O
O	1456	1464	critical	critical	JJ	B-NP
O	1465	1475	downstream	downstream	JJ	I-NP
O	1476	1483	targets	target	NNS	I-NP
O	1484	1486	of	of	IN	B-PP
O	1487	1490	BMP	BMP	NN	B-NP
O	1490	1491	-	-	HYPH	B-NP
O	1491	1492	2	2	CD	I-NP
O	1493	1502	signaling	signaling	NN	I-NP
O	1503	1505	in	in	IN	B-PP
B-Cell	1506	1508	PC	PC	NN	B-NP
I-Cell	1509	1514	cells	cell	NNS	I-NP
O	1514	1515	.	.	.	O

O	1516	1523	Notably	Notably	RB	B-ADVP
O	1523	1524	,	,	,	O
O	1525	1528	the	the	DT	B-NP
O	1529	1539	activation	activation	NN	I-NP
O	1540	1542	of	of	IN	B-PP
O	1543	1549	BMPRII	BMPRII	NN	B-NP
O	1550	1552	by	by	IN	B-PP
O	1553	1556	BMP	BMP	NN	B-NP
O	1556	1557	-	-	HYPH	O
O	1557	1558	2	2	CD	B-NP
O	1559	1561	is	be	VBZ	B-VP
O	1562	1570	required	require	VBN	I-VP
O	1571	1574	for	for	IN	B-PP
O	1575	1585	modulation	modulation	NN	B-NP
O	1586	1588	of	of	IN	B-PP
O	1589	1593	Smad	Smad	NN	B-NP
O	1594	1604	activation	activation	NN	I-NP
O	1605	1607	by	by	IN	B-PP
O	1608	1610	NF	NF	NN	B-NP
O	1610	1611	-	-	HYPH	B-NP
O	1611	1617	kappaB	kappaB	NN	I-NP
O	1618	1620	in	in	IN	B-PP
B-Cell	1621	1623	PC	PC	NN	B-NP
I-Cell	1624	1629	cells	cell	NNS	I-NP
O	1629	1630	.	.	.	O

O	1631	1636	Based	Base	VBN	B-PP
O	1637	1639	on	on	IN	B-PP
O	1640	1644	ChIP	ChIP	NN	B-NP
O	1645	1653	analysis	analysis	NN	I-NP
O	1653	1654	,	,	,	O
O	1655	1658	the	the	DT	B-NP
O	1659	1674	transcriptional	transcriptional	JJ	I-NP
O	1675	1685	regulation	regulation	NN	I-NP
O	1686	1688	of	of	IN	B-PP
O	1689	1692	BMP	BMP	NN	B-NP
O	1692	1693	-	-	HYPH	B-NP
O	1693	1694	2	2	CD	I-NP
O	1695	1699	gene	gene	NN	I-NP
O	1700	1702	by	by	IN	B-PP
O	1703	1705	NF	NF	NN	B-NP
O	1705	1706	-	-	HYPH	O
O	1706	1712	kappaB	kappaB	NN	B-NP
O	1713	1716	may	may	MD	B-VP
O	1717	1719	be	be	VB	I-VP
O	1720	1729	partially	partially	RB	I-VP
O	1730	1740	attributed	attribute	VBN	I-VP
O	1741	1743	to	to	TO	B-PP
O	1744	1751	binding	bind	VBG	B-VP
O	1752	1754	to	to	TO	I-VP
O	1755	1761	kappab	kappab	VB	I-VP
O	1762	1766	site	site	NN	B-NP
O	1767	1769	on	on	IN	B-PP
O	1770	1773	the	the	DT	B-NP
O	1774	1777	BMP	BMP	NN	I-NP
O	1777	1778	-	-	HYPH	I-NP
O	1778	1779	2	2	CD	I-NP
O	1780	1788	promoter	promoter	NN	I-NP
O	1788	1789	.	.	.	O

O	1790	1801	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1801	1802	:	:	:	O
O	1803	1806	The	The	DT	B-NP
O	1807	1811	data	datum	NNS	I-NP
O	1812	1819	suggest	suggest	VBP	B-VP
O	1820	1824	that	that	IN	B-SBAR
O	1825	1829	PI3K	PI3K	NN	B-NP
O	1829	1830	/	/	SYM	B-NP
O	1830	1833	Akt	Akt	NN	I-NP
O	1833	1834	-	-	HYPH	B-NP
O	1834	1836	NF	NF	NN	I-NP
O	1836	1837	-	-	HYPH	B-NP
O	1837	1843	kappaB	kappaB	NN	I-NP
O	1844	1848	axis	axis	NN	I-NP
O	1849	1852	may	may	MD	B-VP
O	1853	1860	promote	promote	VB	I-VP
B-Multi-tissue_structure	1861	1863	PC	PC	NN	B-NP
I-Multi-tissue_structure	1864	1868	bone	bone	NN	I-NP
O	1869	1879	metastasis	metastasis	NN	I-NP
O	1880	1882	in	in	IN	B-PP
O	1883	1887	part	part	NN	B-NP
O	1888	1890	by	by	IN	B-PP
O	1891	1901	regulating	regulate	VBG	B-VP
O	1902	1915	transcription	transcription	NN	B-NP
O	1916	1919	and	and	CC	O
O	1920	1930	activation	activation	NN	B-NP
O	1931	1933	of	of	IN	B-PP
O	1934	1937	the	the	DT	B-NP
O	1938	1941	BMP	BMP	NN	I-NP
O	1941	1942	-	-	HYPH	B-NP
O	1942	1943	2	2	CD	I-NP
O	1943	1944	-	-	HYPH	I-NP
O	1944	1948	Smad	Smad	NN	I-NP
O	1949	1958	signaling	signaling	NN	I-NP
O	1959	1966	cascade	cascade	NN	I-NP
O	1967	1969	in	in	IN	B-PP
B-Cell	1970	1981	osteotropic	osteotropic	JJ	B-NP
I-Cell	1982	1984	PC	PC	NN	I-NP
I-Cell	1985	1990	cells	cell	NNS	I-NP
O	1990	1991	.	.	.	O

